ELISpot And Fluorospot Assay Market Dynamics: Growth Drivers and Restraints

 The global ELISpot and fluorospot assay market size is expected to reach USD 449.97 billion by 2030, registering a CAGR of 6.3% from 2024 to 2030, according to a new report by Grand View Research, Inc. The market is rising due to increasing incidences of chronic and infectious diseases, growing drug discovery activities, and expanding applications in research and diagnostics. These assays are particularly valuable in understanding immune responses, especially in the context of cancer.

ELISpot and Fluorospot assays are crucial for cancer research. They detect tumor-reactive T-cells, map epitopes, identify antigens, and monitor vaccine responses. These assays are particularly useful for studying cancers linked to HPV and HBV, such as HCC and cervical cancer. Tumor-specific vaccines are often tested using these assays, as demonstrated with the HPV vaccine. ELISpot helps researchers develop new treatments for metastatic cervical cancer by assessing T-cell responses and developing immunotherapy strategies using dendritic cells or virus-vectored vaccines.

The report “ELISpot And Fluorospot Assay Market Size, Share & Trends Analysis Report By Product (Assay Kits, Analyzers), By Application (Research Appliances, Diagnostics Applications), By End Use, By Region, And Segment Forecasts, 2024 – 2030” is available now to Grand View Research customers and can also be purchased directly

 

ELISpot and Fluorospot assays are versatile tools with growing applications. They evaluate high-dose IL-2 treatment for melanoma and renal cell carcinoma and are crucial for cancer research driven by rising cancer cases. Beyond cancer, these assays assess drug effects on the immune system and are vital for vaccine development. The ELISpot test is widely used in clinical trials, as numerous global studies demonstrate. Market players are developing advanced ELISpot and Fluorospot assay-based solutions, such as Revvity's FDA-approved T-SPOT test for latent TB screening.

ELISpot And Fluorospot Assay Market Report Highlights:

  • Based on product, the assay kits segment dominated the market in 2023 with a share of 49.34%. ELISpot assays are highly sensitive tools for measuring immune responses at the single-cell level. They use sandwich immuno-enzyme technology to detect and quantify secretory products, making them valuable in fields like transplantation, T-cell regulation, vaccine development, and more
  • The diagnostic application segment held the largest market share of 65.94% in 2023. ELISpot and Fluorospot assays are highly sensitive tools for diagnosing infectious diseases and autoimmune conditions. The growing fields of immunology and oncology are driving demand for these assays
  • Hospitals and clinical labs end use segment held the largest revenue share of 46.31% in 2023 due to its advanced healthcare and R&D. The T-SPOT.TB test, an IGRA, is widely used for TB diagnosis in the U.S. Its accuracy and ease of use have contributed to its growing adoption, replacing the tuberculin skin test in many cases
  • North America dominated the global market with a revenue share of 52.50% in 2023 due to its advanced healthcare and R&D. The T-SPOT.TB test, an IGRA, is widely used for TB diagnosis in the U.S. Its accuracy and ease of use have contributed to its growing adoption, replacing the tuberculin skin test in many cases

 

Order your free sample copy of “ELISpot And Fluorospot Assay Market Report 2024 - 2030, published by Grand View Research

 

ELISpot And Fluorospot Assay Market Segmentation

Grand View Research has segmented the global ELISpot and fluorospot assay market based on product, application, end use, and region:

ELISpot And Fluorospot Assay Product Outlook (Revenue, USD Million, 2018 – 2030)

  • Assay Kits
  • Analyzers
  • Ancillary Products

ELISpot And Fluorospot Assay Application Outlook (Revenue, USD Million, 2018 – 2030)

  • Research Applications
    • Vaccine Development
    • Clinical Trials
    • Cancer Research
  • Diagnostics Applications
    • Infectious Disease
    • Cancer
    • Autoimmune Disease
    • Allergy and Organ Transplantations

ELISpot And Fluorospot Assay End Use Outlook (Revenue, USD Million, 2018 – 2030)

  • Hospital and Clinical Labs
  • Academic and Research Institutes
  • Biopharmaceutical Company

ELISpot And Fluorospot Assay Regional Outlook (Revenue, USD Million, 2018 – 2030)

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • UK
    • Germany
    • France
    • Italy
    • Spain
    • Denmark
    • Sweden
    • Norway
  • Asia Pacific
    • Japan
    • China
    • India
    • South Korea
    • Australia
    • Thailand
  • Latin America
    • Brazil
    • Argentina
  • MEA
    • South Africa
    • Saudi Arabia
    • UAE
    • Kuwait

 

§   

List of Key Players in the ELISpot And Fluorospot Assay Market

  • Becton, Dickinson and Company
  • U-Cytech Biosciences
  • Cellular Technologies Limited
  • Mabtech AB
  • Abcam
  • Autoimmun Diagnostika GmbH
  • Lophius Biosciences GmbH
  • Bio-Connect B.V.
  • Oxford Immunotec
  • Bio-Techne Corporation

 

About Grand View Research:

Grand View Research, Inc. is a market research and consulting company that provides off-the-shelf, customized research reports and consulting services. To help clients make informed business decisions, we offer market intelligence studies, ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials, and energy. With a deep-seated understanding of varied business environments, Grand View Research provides strategic objective insights. For more information, visit www.grandviewresearch.com

 

Contact:

Sherry James

Corporate Sales Specialist, USA

Grand View Research, Inc.

Phone: 1-415-349-0058
Email:  sales@grandviewresearch.com

Comments

Post a Comment

Popular posts from this blog

Drug Addiction - Pipeline Review, H1 2017 Market Overview and trends research report

Radiant insights, inc latest Pharmaceutical and Healthcare disease pipeline guide Drug Addiction - Pipeline Review, H1 2017, provides an overview of the Drug Addiction (Central Nervous System) pipeline landscape. Drug addiction, also called substance dependence or chemical dependency, is a disease that is characterized by a destructive pattern of drug abuse that leads to significant problems involving tolerance to or withdrawal from the substance. Drug addiction symptoms or behaviors include recurrent drug use that results in a lack of meeting important obligations at work, school, or home, inability to sleep, awake at unusual times, unusual laziness, loss of or increased in appetite, changes in eating habits, cold, sweaty palms; shaking hands., red, watery eyes; pupils larger or smaller than usual and unusual smells on breath, body or clothes. Report Highlights Radiant insights, inc Pharmaceutical and Healthcare latest pipeline guide Drug Addiction - Pipeline Review, H1 2017, p
Read more

All Countries Dialyzer Industry 2013-2028 - Market Size, Share, Outlook, Growth, Key Players and Forecast

The global Dialyzer market was valued at $XX million in 2018, and Radiant Insights, Inc analysts predict the global market size will reach $XX million by the end of 2028, growing at a CAGR of XX% between 2018 and 2028. This report provides detailed historical analysis of global market for Dialyzer from 2013-2018, and provides extensive market forecasts from 2019-2028 by region/country and subsectors. It covers the sales volume, price, revenue, gross margin, historical growth and future perspectives in the Dialyzer market. Download Free Sample Report @ https://www.radiantinsights.com/research/2013-2028-report-on-global-dialyzer-market/request-sample Leading players of Dialyzer including: • Fresenius Medical Care • Baxter • Nipro • Asahi Kasei • Toray • B.Braun • Nikkiso • Medtronic • Kawasumi • Medica • Wego • Lengthen • Peony Medical • Chengdu OCI • Bain Medical Equipment Market split by Type, can be divided into: • Flat Type Dialyzer • Coil Tube Dialyzer • Ho
Read more

Insights into the Medical Waste Disposal Category: A Comprehensive Procurement Intelligence Report

  Medical Waste Disposal Category Overview The medical waste disposal category is anticipated to grow at a CAGR of 6.0% from 2023 to 2030. Appropriate disposal of medical trash is the key challenge for healthcare providers across the globe. Rising awareness about the benefits of proper medical waste management for treatment, recycling, and disposal of medical trash has boosted the growth of the category. According to the World Health Organization Study Report 2022, countries with low income generate over 0.2 kg of medical trash per day per hospital bed, whereas countries with high income generate hazardous waste of up to 0.5 kg per hospital bed each day. Moreover, rising government initiatives and strict rules and regulations for waste management are also expected to drive the category. For instance, in December 2022, an MOU was signed between the Center for Health Environment Research and Development and Can Tho Central General Hospital under USAID’s Reducing Pollution Project. This
Read more